1. Home
  2. TENX vs CLIR Comparison

TENX vs CLIR Comparison

Compare TENX & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • CLIR
  • Stock Information
  • Founded
  • TENX 1967
  • CLIR 2008
  • Country
  • TENX United States
  • CLIR United States
  • Employees
  • TENX N/A
  • CLIR N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • CLIR Industrial Machinery/Components
  • Sector
  • TENX Health Care
  • CLIR Industrials
  • Exchange
  • TENX Nasdaq
  • CLIR Nasdaq
  • Market Cap
  • TENX 27.3M
  • CLIR 30.7M
  • IPO Year
  • TENX N/A
  • CLIR 2012
  • Fundamental
  • Price
  • TENX $6.37
  • CLIR $0.52
  • Analyst Decision
  • TENX Strong Buy
  • CLIR Strong Buy
  • Analyst Count
  • TENX 4
  • CLIR 1
  • Target Price
  • TENX $16.67
  • CLIR $2.00
  • AVG Volume (30 Days)
  • TENX 47.8K
  • CLIR 89.1K
  • Earning Date
  • TENX 11-12-2025
  • CLIR 11-13-2025
  • Dividend Yield
  • TENX N/A
  • CLIR N/A
  • EPS Growth
  • TENX N/A
  • CLIR N/A
  • EPS
  • TENX N/A
  • CLIR N/A
  • Revenue
  • TENX N/A
  • CLIR $2,983,000.00
  • Revenue This Year
  • TENX N/A
  • CLIR $13.13
  • Revenue Next Year
  • TENX N/A
  • CLIR $143.88
  • P/E Ratio
  • TENX N/A
  • CLIR N/A
  • Revenue Growth
  • TENX N/A
  • CLIR 19.03
  • 52 Week Low
  • TENX $3.25
  • CLIR $0.46
  • 52 Week High
  • TENX $7.89
  • CLIR $1.72
  • Technical
  • Relative Strength Index (RSI)
  • TENX 69.69
  • CLIR 40.00
  • Support Level
  • TENX $6.02
  • CLIR $0.46
  • Resistance Level
  • TENX $6.50
  • CLIR $0.57
  • Average True Range (ATR)
  • TENX 0.15
  • CLIR 0.03
  • MACD
  • TENX 0.04
  • CLIR -0.01
  • Stochastic Oscillator
  • TENX 78.56
  • CLIR 41.93

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

Share on Social Networks: